The Necrobiosis Lipodica (NL) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for necrobiosis lipoidica has seen significant growth in recent years. The market size is projected to increase from $4.08 billion in 2024 to $4.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%.
The Necrobiosis Lipoidica (NL) global market is projected to reach $5.65 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.7%.
Download Your Free Sample of the 2025 Necrobiosis Lipodica (NL) Market Report and Uncover Key Trends Now!The key drivers in the necrobiosis lipodica (nl) market are:
• Increase in the aging population
• Rising awareness about skin health and aesthetics
• Growth in disposable income
• A rise in government initiatives
The necrobiosis lipodica (NL) market covered in this report is segmented –
1) By Treatment: Therapy, Drugs, Other Treatments
2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration
3) By Diagnosis: Skin Biopsy, Histopathology, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Therapy: Phototherapy, Laser Therapy, Wound Care And Compression Therapy, Physical Therapy And Rehabilitation
2) By Drugs: Topical Corticosteroids, Intralesional Corticosteroids, Systemic Corticosteroids, Immunomodulators, Biologics, Antiplatelet Agents, Antioxidants And Vasodilators, Antibiotics
3) By Other Treatments: Surgical Excision And Skin Grafting, Hyperbaric Oxygen Therapy (HBOT), Platelet-Rich Plasma (PRP) Therapy, Stem Cell Therapy And Regenerative Medicine, Alternative And Herbal Treatments
The key trends in the necrobiosis lipodica (nl) market are:
• Advanced treatment options are becoming a significant trend in the necrobiosis lipoidica market.
• Implementation and development of advanced diagnostic techniques is a rising trend.
• The market is being shaped by the increasing adoption of biologics.
• An increase in advanced clinical trials and emerging regenerative therapies are shaping the future of the market.
Major players in the necrobiosis lipodica (nl) market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• Novartis AG
• Sanofi S.A.
• GlaxoSmithKline plc
• Eli Lilly and Company
• Regeneron Pharmaceuticals Inc.
• Daiichi Sankyo Company Limited
• Bausch Health Companies Inc.
• Galderma Laboratories L.P.
• Dr. Reddy's Laboratories Ltd.
• Incyte Pharmaceuticals
• Celltrion Healthcare Co. Ltd.
• Almirall S.A.
• Samsung Bioepis Co. Ltd.
• Hovione
• Momenta Pharmaceuticals Inc.
• HanAll Biopharma Co. Ltd.
• Processa Pharmaceuticals
North America was the largest region in the necrobiosis lipoidica market in 2024